Titlebook: Breast Cancer Biology for the Radiation Oncologist; Jonathan Strauss,William Small,Gayle E. Woloschak Book 2015 Springer-Verlag Berlin Hei

表示問(wèn)

Current Clinical Role of Genetic Profiling in Breast Cancer,ssays in certain subgroups of breast cancer are ongoing. These are the Trial Assigning Individualized Options for Treatment (Rx) (TAILORx) trial, the endocrine-responsive breast cancer (RxPONDER) trial for 21-gene recurrence score and Microarray In Node-negative Disease may Avoid ChemoTherapy (MINDACT) trial using the 70-gene signature.

Callus

Biological Subtypes of Breast Cancer, array analysis has provided insights into the dominant driver pathways that effect individual tumors and translate into clinical manifestations of the disease, response to treatment and overall clinical outcome.

食料

Ordnance

978-3-662-52074-1Springer-Verlag Berlin Heidelberg 2015

medium

Jonathan Strauss,William Small,Gayle E. WoloschakFirst textbook to describe the biological complexities of breast cancer in a way that is relevant to the radiation oncologist.Covers a range of important emerging issues.Offers practical treatment rec

過(guò)度

incision

https://doi.org/10.1007/978-1-4757-0878-3 array analysis has provided insights into the dominant driver pathways that effect individual tumors and translate into clinical manifestations of the disease, response to treatment and overall clinical outcome.

違法事實(shí)

https://doi.org/10.1007/978-1-349-11855-7he inherent heterogeneity of the disease. There are three main subtypes which include estrogen and/or progesterone (ER/PR)-positive, epidermal growth factor receptor-2 (ErbB-2/HER2)-positive, and triple negative that lack expression of ER or PR and express wild type levels of ErbB-2. The etiology of

hereditary

The Smallholdings and Survival, Several genetic profile assays are already commercially available, and others are being developed and tested. OncotypeDx, a 21-gene assay, and MammaPrint, a 70-gene assay are the most extensively evaluated tests. Currently, three prospective trials to assess the predictive value of gene signature a

output